Myocarditis in the Setting of Cancer Therapeutics
Open Access
- 2 July 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 140 (1), 80-91
- https://doi.org/10.1161/circulationaha.118.034497
Abstract
Recent developments in cancer therapeutics have improved outcomes but have also been associated with cardiovascular complications. Therapies harnessing the immune system have been associated with an immune-mediated myocardial injury described as myocarditis. Immune checkpoint inhibitors are one such therapy with an increasing number of case and cohort reports describing a clinical syndrome of immune checkpoint inhibitor–associated myocarditis. Although the full spectrum of immune checkpoint inhibitor–associated cardiovascular disease still needs to be fully defined, described cases of myocarditis range from syndromes with mild signs and symptoms to fatal events. These observations in the clinical setting stand in contrast to outcomes from randomized clinical trials in which myocarditis is a rare event that is investigator reported and lacking in a specific case definition. The complexities associated with diagnosis, as well as the heterogeneous clinical presentation of immune checkpoint inhibitor–associated myocarditis, have made ascertainment and identification of myocarditis with high specificity challenging in clinical trials and other data sets, limiting the ability to better understand the incidence, outcomes, and predictors of these rare events. Therefore, establishing a uniform definition of myocarditis for application in clinical trials of cancer immunotherapies will enable greater understanding of these events. We propose an operational definition of cancer therapy-associated myocarditis that may facilitate case ascertainment and report and therefore may enhance the understanding of the incidence, outcomes, and risk factors of this novel clinical syndrome.Keywords
This publication has 41 references indexed in Scilit:
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaBlood, 2013
- Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix ChangesPLOS ONE, 2012
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJournal of the American College of Cardiology, 2009
- Noninvasive Imaging in MyocarditisJournal of the American College of Cardiology, 2006
- Diagnostic Performance of Cardiovascular Magnetic Resonance in Patients With Suspected Acute Myocarditis: Comparison of Different ApproachesJournal of the American College of Cardiology, 2005
- Cardiovascular Magnetic Resonance Assessment of Human MyocarditisCirculation, 2004
- Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunctionIntensive Care Medicine, 2003
- Ventricular remodeling in active myocarditisAmerican Heart Journal, 1999
- Echocardiographic findings in myocarditisThe American Journal of Cardiology, 1988
- Lyme Carditis: Cardiac Abnormalities of Lyme DiseaseAnnals of Internal Medicine, 1980